EvidenceCare key facts
as of Oct 2026- Developer of a clinical decision support platform intended to integrate seamlessly into a clinician's electronic health record workflow, delivering customized, interactive, and evidence-based…
- EvidenceCare is valued at approximately $77.4M as of Oct 2026, set at its later-stage round, Mar 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $56.8M across 3 recorded rounds; the latest was Early Stage VC ($9.6M) in Mar 2025.
- Notable investors include Service Provider Capital, Keiretsu Forum, Texas Medical Center, Cultivation Capital, Tectonic Ventures — 12 tracked in total.
- EvidenceCare has filed 4 Form Ds with the SEC since 2020, most recently Mar 2025 ($9.6M sold to 66 investors).
- Status: Privately Held (backing).
Valued at $77.4M at its later-stage round, Mar 2025. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch EvidenceCare: the Monday email on marks, rounds and moves
EvidenceCare funding rounds
3 roundsWho backs EvidenceCare
12+EvidenceCare valuation
EvidenceCare was valued at $77.4 million at its later-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has EvidenceCare raised?
EvidenceCare has raised $56.8 million in total; 3 of its rounds are on record, from 2020 on. The largest on record was a $9.6 million early-stage round in Mar 2025.
EvidenceCare has filed 4 Form Ds with the SEC since 2020, most recently in Mar 2025 ($9.6 million sold to 66 investors).
EvidenceCare investors
12 investors are on record for EvidenceCare, including Service Provider Capital, Keiretsu Forum, Texas Medical Center and Cultivation Capital. The early-stage round in Mar 2025 drew 66 investors.
About EvidenceCare
Developer of a clinical decision support platform intended to integrate seamlessly into a clinician's electronic health record workflow, delivering customized, interactive, and evidence-based guidance directly into the care process. The company's platform enhances clinical decision-making through sophisticated clinical decision support system technology, enabling healthcare providers to improve quality and safety, minimize liability, and increase operational efficiency while optimizing compliance with government-mandated quality programs.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2014
- Employees
- 45
- Website
- evidence.care/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.